• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Providers & ServicesBiocorrx
    Picture of Biocorrx logo

    BICX — Biocorrx News Story

    $0.210.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapFalling Star
    • Market Cap
      $6.28m
    • Enterprise Value
      $13.21m
    • Revenue
      $0.80m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • BICX Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    BICX Dividends
    All News

    Brief: BioCorRx Provides Update On BICX102

    Picture of Biocorrx logoBiocorrx
    07/08/2018 12:42
    Aug 7 (Reuters) - BioCorRx Inc  BICX.PK :
        * BIOCORRX PROVIDES UPDATE ON BICX102
    
    Source text for Eikon:  ID:nGNX1njGYC 
    Further company coverage:  BICX.PK 
    
     ((Reuters.Briefs@thomsonreuters.com;))
    

    Recent news on Biocorrx

    See all news
    • Brief: BioCorRx Submits Fast Track Application To FDA For Bicx104, An Implantable Biodegradable Naltrexone Pellet For The Treatment Of Opioid Use Disorder

      18/07/2023 14:15
    • Brief: Biocorrx Announces Completion Of Treatment Phase Of Study Subjects And Preliminary Safety Data From Phase I Clinical Trial Of Bicx104

      19/01/2023 13:48
    • Brief: BioCorRx Partners With Government Plus To Expand Its Beat Addiction Recovery Program In The United States

      07/12/2022 14:13
    • Brief: Biocorrx Completes Final Subject Enrollment In Phase I Clinical Trial Of Bicx104, An Implantable Naltrexone Pellet For The Treatment Of Opioid Use Disorder

      13/10/2022 13:39
    • Brief: BioCorRx Begins Recruitment for Clinical Trial of BICX104

      27/04/2022 13:41

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.